EN PL

EMA: Draft guideline on the clinical investigation of human normal immunoglobulin for intravenous administration (IVIg)

08.04.2010
The purpose of this guideline is to provide applicants and regulators with harmonized guidance for applications for marketing authorization for IVIg.